EXPERTS have warned over hundreds rushed to hospital after using weight loss jabs – as half a million Brits now use the ...
A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity ...
Figures from the Medicines and Healthcare products Regulatory Agency show that increasing numbers need medical treatment ...
New data obtained has found cases soared over the four weeks to the end of November, with an extra 118 hospitalisations ...